Analysis of temperament/mizaj of men with benign prostatic hyperplasia: a novel research
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20214568Keywords:
Benign prostatic hyperplasia, Mizaj, Phlegmatic, Temperament, UnaniAbstract
Background: Benign prostatic hyperplasia (BPH) is a commonest health disorder affecting elderly men characterized by lower urinary tract symptoms (LUTS). It is a non-malignant neoplasm of men with an incidence of approximately 20% in their 40s and reaches up to 90% in their 80s. Androgens play a vital role in its development. In Unani system of medicine, BPH can be traced under the headings of waram-i-unuq al-mathāna (swelling at the bladder neck) and insidād majrā-i-mathāna (bladder outlet obstruction). As per the basic fundamentals of the said system of medicine, a disease arises due to the humoral imbalance or distemperament. Knowing the temperament of men having LUTS associated with BPH will help in appropriate selection of herbs and other Unani medicinal remedies for its treatment and productive research. It might prove a breakthrough in managing BPH and decreasing burden on conventional medicines and their side-effects.
Methods: The current study was based on a questionnaire and examination of sixty (60) diagnosed cases of BPH, as per the standard temperament chart recommended in Unani literature.
Results: The study revealed that 73.3% of BPH patients were having phlegmatic temperament (balghami al-mizaj), 20% having sanguine (damwi al-mizaj) and 6.7% were of bilious temperament (safrawi al-mizaj).
Conclusions: BPH was found to be more prevalent among men with phlegmatic temperament (balghami al-mizaj) and hence is likely a phlegmatic disorder (marad-i-balghami) or in other words phlegmatic distemperament (su-e-mizaj balghami).
References
Das S. A concise text book of surgery. 10th ed. Kolkata: Das; 2018: 1140-1145,1152,1154.
Longo L, Fauci S, kasper L, Braunwald E, Hauser L, Jamesom L, eds. Harrison’s principles of internal medicine. 18th edn. Vol I. New York: McGraw Hills; 2012:804-805.
Roehrborn CG. Male lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH). Med Clin North Am. 2011;95(1):87-100.
Ahmad SI. Kulliyat-i-Asri. New Delhi: New Public Press and Aala Public Press; 1983:9, 91, 184.
Sina SR. Alqanoon fil tib (The Canon of Medicine) (Urdu translation by Ghulam Hasnain kantoori). Vol III. New Delhi: Ejaz Publishing House; 2010:1018-1019,1023-1024,1028-1030.
Jurjani AH. Zakhīra khwarzam shahi (The Treasure of Khwarzam Shah) (Urdu translation by Khan Hadi Hussain). New Delhi: Idara Kitābul Shifa; YNM. Vol VI. 525, 526, 531.
Patel ND, Parsons JK. Epidemiology and etiology of benign prostatic hyperplasia and bladder outlet obstruction. Indian J Urol. 2014;30(2):170-6.
American Urological Association Practice Guidelines Committee. AUA guidelines on management of benign prostatic hyperplasia: diagnosis and treatment recommendations. J Urol. 2003;170(2 Pt 1):530-47.
Kumar V, Abbas AK, Fausto, Mitchel, eds. Robin’s basic pathology. 8th ed. Philadelphia: Saunders; 2007: 696-697.
Nicholson TM, Ricke WA. Androgens and estrogens in benign prostatic hyperplasia: past, present and future. Differentiation. 2011;82:184-99.
Ajayi A, Abraham K. Understanding the role of estrogen in the development of benign prostatic hyperplasia. Afr J Urol. 2018;24(2):93-7.
Kabiruddin M. Kitāb Al-Akhlāt. New Delhi: CCRUM; 2009: 79,85.
Kabiruddin M. Kulliyat-i-Nafeesi. Part I. New Delhi: Idara Kitābul Shifa; 1954:62-63.
Parsons JK, Sarma AV, McVary K, Wei JT. Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions. J Urol. 2013;189:102-6.
Chandpuri Q. Mojiz al-Qanūn. 3rd edn. New Delhi: NCPUL; 1998:116,120.
Khan MA. Aksīr-i-Azam (New version by Kabiruddin). New Delhi: Ejaz Publishing House; 2010:728-734.
